In this study, HL reflected by PTA threshold was not only significantly correlated with AD neuropathological biomarker of P-tau (S199) level in CSF (Tables 4, 5), but also with BBB impairment reflected by the elevated MMP-3 level in CSF from AD patients (Tables 6, 7). This evidence concerns the gene MAPT and Alzheimer disease.